Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4033191010 | Product containing rimegepant in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 4033192015 | Rimegepant-containing product in oromucosal dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rimegepant-containing product in oromucosal dose form | Is a | Rimegepant-containing product | true | Inferred relationship | Some | ||
| Rimegepant-containing product in oromucosal dose form | Has manufactured dose form | Oromucosal dose form | true | Inferred relationship | Some | ||
| Rimegepant-containing product in oromucosal dose form | Plays role | Antimigraine therapeutic role | true | Inferred relationship | Some | ||
| Rimegepant-containing product in oromucosal dose form | Is a | Product manufactured as oromucosal dose form | true | Inferred relationship | Some | ||
| Rimegepant-containing product in oromucosal dose form | Has active ingredient | Rimegepant | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rimegepant only product in oromucosal dose form | Is a | True | Rimegepant-containing product in oromucosal dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR